AP
ASXC

AlpInvest Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

AlpInvest Partners’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,302
Closed -$1.61M – 26
2018
Q3 		$1.61M Buy
+21,302
New +$1.44M 3.43% 9

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlpInvest Partners's ASXC Position: Q4 2018 in Review

AlpInvest Partners sold out of Asensus Surgical, Inc. (ASXC) in Q4 2018, closing a stake of 21,302 shares — an estimated $1.61M sold.

AlpInvest Partners first reported a position in ASXC in Q3 2018 and held it in 1 quarter. The position peaked at $1.61M in Q3 2018. 150 funds tracked by Wall St. Rank hold ASXC as of Q4 2018.

  • AlpInvest Partners reported no remaining Asensus Surgical, Inc. position as of Q4 2018 after selling out during the quarter.
  • AlpInvest Partners sold 21,302 Asensus Surgical, Inc. shares in Q4 2018, an estimated $1.61M.
  • AlpInvest Partners first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 1 quarter.
  • AlpInvest Partners's Asensus Surgical, Inc. position peaked at $1.61M in Q3 2018.
  • 150 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2018.

Based on AlpInvest Partners's 13F filing for Q4 2018, filed 14 Feb 2019.